Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype 1 infection

2015 ◽  
Vol 21 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Hideaki Kinugasa ◽  
Fusao Ikeda ◽  
Kouichi Takaguchi ◽  
Chizuru Mori ◽  
Takehiro Matsubara ◽  
...  
Keyword(s):  
Therapeutic Efficacy ◽  
Low Frequency ◽  
Drug Resistant ◽  
Resistant Virus ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1 ◽  
Chronic Hcv ◽  
Drug Resistant Virus

The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection

2014 ◽  
Vol 46 ◽  
pp. e20
Author(s):  
F.S. Macaluso ◽  
M. Maida ◽  
C. Cammà ◽  
G. Cabibbo ◽  
R. Fonte ◽  
...  
Keyword(s):  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1 ◽  
Chronic Hcv

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

Hepatology ◽  
2004 ◽  
Vol 39 (6) ◽  
pp. 1702-1708 ◽  
Author(s):  
Lennox J. Jeffers ◽  
William Cassidy ◽  
Charles D. Howell ◽  
Sylvia Hu ◽  
K. Rajender Reddy
Keyword(s):  
Black American ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1 ◽  
Chronic Hcv ◽  
Peginterferon Alfa
Sign in / Sign up

Export Citation Format

Share Document